We are expanding our product portfolio by offering assays and services for the Modaplex, a novel molecular diagnostic platform that bridges the gap between qPCR and Next Generation Sequencing.

Its unique combination of PCR amplification and parallel performed capillary electrophoresis enables the quantification of up to 2,000 DNA and RNA targets within 3.5 hours. Explore all the additional advantages it creates for your molecular diagnostics, either for customized development, routine use, or for technology transfer.

Learn more

ESMO 2019 Congress - European Society For Medical Oncology
27th Sep - 1st Oct 2019 / Barcelona / Spain
Hall 3 / Booth 245

Biotype expands highly specific CE-IVD portfolio for chimerism monitoring. 56 Mentype® DIPquant assays are now CE-IVD-registered.

Biotype GmbH, in response to customer demand, now offers the qPCR kit Mentype® DIPquant as an in-vitro diagnostic with European approval. It is the third CE-IVD approved assay for chimerism analysis, alongside Mentype® Chimera® and Mentype® DIPscreen, and it extends the chimerism portfolio for use in in vitro diagnostics.

Learn more

28-06-2019
Biotype Diagnostic and Biotype Innovation join forces

We are excited to announce that Biotype Diagnostic GmbH and Biotype Innovation GmbH have decided to merge their capabilities to form one strong entity. 

Learn more